Literature DB >> 19494070

Expanded multilocus sequence typing for burkholderia species.

Theodore Spilker1, Adam Baldwin, Amy Bumford, Chris G Dowson, Eshwar Mahenthiralingam, John J LiPuma.   

Abstract

PCR primers targeting loci in the current Burkholderia cepacia complex multilocus sequence typing scheme were redesigned to (i) more reliably amplify these loci from B. cepacia complex species, (ii) amplify these same loci from additional Burkholderia species, and (iii) enable the use of a single primer set per locus for both amplification and DNA sequencing.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19494070      PMCID： PMC2725695          DOI： 10.1128/JCM.00770-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Kathleen M Thickett; David Honeybourne; Martin C J Maiden; John R Govan; David P Speert; John J Lipuma; Peter Vandamme; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Multilocus restriction typing: a novel tool for studying global epidemiology of Burkholderia cepacia complex infection in cystic fibrosis.

Authors:  Tom Coenye; John J LiPuma
Journal:  J Infect Dis       Date:  2002-04-23       Impact factor: 5.226

3.  Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.

Authors:  J J LiPuma; B J Dulaney; J D McMenamin; P W Whitby; T L Stull; T Coenye; P Vandamme
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

4.  Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.

Authors:  Daniel Godoy; Gaynor Randle; Andrew J Simpson; David M Aanensen; Tyrone L Pitt; Reimi Kinoshita; Brian G Spratt
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients.

Authors:  Theodore Spilker; Tom Coenye; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Chris Pope; David J Waine; Deborah A Henry; David P Speert; Phil Carter; Peter Vandamme; John J LiPuma; Chris G Dowson
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

7.  Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex.

Authors:  Elke Vanlaere; John J Lipuma; Adam Baldwin; Deborah Henry; Evie De Brandt; Eshwar Mahenthiralingam; David Speert; Chris Dowson; Peter Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2008-07       Impact factor: 2.747

8.  Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.

Authors:  Elke Vanlaere; Adam Baldwin; Dirk Gevers; Deborah Henry; Evie De Brandt; John J LiPuma; Eshwar Mahenthiralingam; David P Speert; Chris Dowson; Peter Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2009-01       Impact factor: 2.747

9.  Multilocus sequence typing breathes life into a microbial metagenome.

Authors:  Eshwar Mahenthiralingam; Adam Baldwin; Pavel Drevinek; Elke Vanlaere; Peter Vandamme; John J LiPuma; Chris G Dowson
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

10.  Environmental Burkholderia cepacia complex isolates in human infections.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Peter Vandamme; John R Govan; David J Waine; John J LiPuma; Luigi Chiarini; Claudia Dalmastri; Deborah A Henry; David P Speert; David Honeybourne; Martin C J Maiden; Chris G Dowson
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883
  10 in total
  50 in total

1.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of Burkholderia pseudomallei: importance of expanding databases with pathogens endemic to different localities.

Authors:  Susanna K P Lau; Bone S F Tang; Shirly O T Curreem; Tsz-Ming Chan; Paolo Martelli; Cindy W S Tse; Alan K L Wu; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

2.  Direct culture-independent Strain typing of Burkholderia cepacia complex in sputum samples from patients with cystic fibrosis.

Authors:  Pavel Drevinek; Sarka Vosahlikova; Klara Dedeckova; Ondrej Cinek; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

3.  Evaluation of different molecular and phenotypic methods for identification of environmental Burkholderia cepacia complex.

Authors:  João Pedro Rueda Furlan; André Pitondo-Silva; Vânia Santos Braz; Inara Fernanda Lage Gallo; Eliana Guedes Stehling
Journal:  World J Microbiol Biotechnol       Date:  2019-02-09       Impact factor: 3.312

4.  Culturing and Characterization of Gut Symbiont Burkholderia spp. from the Southern Chinch Bug, Blissus insularis (Hemiptera: Blissidae).

Authors:  Yao Xu; Eileen A Buss; Drion G Boucias
Journal:  Appl Environ Microbiol       Date:  2016-05-16       Impact factor: 4.792

5.  Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil.

Authors:  C P da Costa Capizzani; N C Caçador; L A G M M Torres; L Tonani; P Vandamme; A L da Costa Darini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-24       Impact factor: 3.267

Review 6.  Twenty years of paradigm-breaking studies of taxonomy and symbiotic nitrogen fixation by beta-rhizobia, and indication of Brazil as a hotspot of Paraburkholderia diversity.

Authors:  Fabiane Paulitsch; Fabio Bueno Dos Reis; Mariangela Hungria
Journal:  Arch Microbiol       Date:  2021-07-10       Impact factor: 2.552

Review 7.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 8.  Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.

Authors:  Mariana Tavares; Mariya Kozak; Alexandra Balola; Isabel Sá-Correia
Journal:  Clin Microbiol Rev       Date:  2020-04-15       Impact factor: 26.132

9.  Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.

Authors:  Kay A Ramsay; Claire A Butler; Stuart Paynter; Robert S Ware; Timothy J Kidd; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

10.  Isolation and characterization of Burkholderia rinojensis sp. nov., a non-Burkholderia cepacia complex soil bacterium with insecticidal and miticidal activities.

Authors:  Ana Lucia Cordova-Kreylos; Lorena E Fernandez; Marja Koivunen; April Yang; Lina Flor-Weiler; Pamela G Marrone
Journal:  Appl Environ Microbiol       Date:  2013-10-04       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.